Navigation Links
EntreMed Secures $10 Million Strategic Financing
Date:1/23/2012

ROCKVILLE, Md., Jan. 23, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has secured $10 million in financing with strategic accredited investors, including IDG-Accel China Growth Fund II L.P. ("IDG"), Emerging Technology Partners, LLC ("ETP"), and Dr. Tak W. Mak, Director of The Campbell Family Institute for Cancer Research.

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO )

The Company entered into purchase agreements with the investors, pursuant to which the Company has agreed to issue and sell to the investors convertible notes in the aggregate principal amount of $10 million.  The investors also will be issued warrants covering a number of shares of common stock equal to 20% of the principal amount of the notes, divided by $1.15.  The warrants are exercisable at $1.40 per share.  The closing of the transaction is anticipated to occur on or about January 27, 2012 upon the satisfaction of certain conditions. 

At the closing, IDG and ETP have the right to designate in the aggregate two members of the Company's Board of Directors.  In addition, it is expected that the Company will select an interim Chief Executive Officer.  

Subject to the approval of the Company's stockholders at the 2012 stockholder meeting, the notes will automatically and immediately convert into shares of common stock and the warrants will become exercisable.  The notes have a maturity date of August 31, 2012, bear an interest rate of 6% and will convert at a conversion price of $1.15 per share.  The conversion price reflects the 10-day average closing sale price ending on January 20, 2012.  The notes are not convertible, and the war
'/>"/>

SOURCE EntreMed
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... to present a corporate overview and update at the Piper ... 2, 2014, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific ... New York . A live audio webcast ... section of Arena,s website at www.arenapharm.com . A replay ...
(Date:11/24/2014)... 24, 2014 Luoxis Diagnostics, Inc., a ... today announced the presentation of three clinical and ... a broadly applicable and robust research tool capable ... in response to injury, illness, or stress.  In ... with Luoxis, academic and pharmaceutical research partners, RedoxSYS ...
(Date:11/24/2014)... The Female Health Company (NASDAQ-CM: FHCO), today ... to discuss its operating results for the fourth quarter ... December 2, 2014 at 11:00 a.m. Eastern Standard Time ... earlier the same day. Shareholders and other ... dialing 1-877-374-8416 (international participants dial 1-412-317-6716) and asking to ...
Breaking Medicine Technology:Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 2Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 4Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 5The Female Health Company To Report FY2014 Operating Results on Tuesday, December 2, 2014 2
... 24, 2011 Mira Dx announced today that it has ... a pivotal breast cancer study in the January issue of ... coding sequence mutations are associated with breast cancer risk, ... 5% of breast cancer risk. The research identified microRNA disrupting ...
... YORK, Feb. 24, 2011 Reportlinker.com announces that a ... Global Orthopedic Orthotics Industry ... analyzes the worldwide markets for Orthopedic Orthotics in US$ ... Braces, Ankle Braces, & Others) and Orthopedic Support Devices. ...
Cached Medicine Technology:Mira Dx Licenses Triple Negative Breast Cancer Risk Variant from Yale University 2Reportlinker Adds Global Orthopedic Orthotics Industry 2
(Date:11/24/2014)... 2014 Mental health issues affect ... break up families, ruin careers, and generally destroy ... those that suffer,” says Hardy Nutritionals® ... that our specialized nutritional treatments can reverse these ... “Mind Over Matter”, the premiere episode of O2 ...
(Date:11/24/2014)... New York (PRWEB) November 24, 2014 Gersowitz ... today that it has received national Tier recognition in the ... Firms.” Achieving a tiered ranking signals a unique combination of ... are very proud to receive this honor and especially grateful ... made this important honor and ranking possible,” said Jeff S. ...
(Date:11/23/2014)... (PRWEB) November 24, 2014 iFitDress.com, a well-known ... long black evening gowns . They are now offered ... special offer will last from now to Dec. 15. The ... market. , All the company’s high quality items are ideal ... spending a large sum of money. All its new mint ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 Pro Ace Care, ... that it will now be providing an 8 year warranty ... hot water tank installations went up due to the impending ... assure its customers of the premium service that the company ... 8 year warranty on John Wood and Bradford hot water ...
(Date:11/23/2014)... Locks-Magnetic.com, a notable magnetic locks maker, has released a ... are available at low rates up to 30% off. ... new emergency doors. The emergency door adopts fireproof material ... several colors. All of the products are top-quality guaranteed. ... not as easy as many people think. As ...
Breaking Medicine News(10 mins):Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2
... this holiday season? It’s one of the biggest fashion trends this ... back, neck and shoulder pain, headaches and possibly even arthritis. // ... headaches and what I usually do is look for their purse ... on the medical staff at Baylor Medical Center at Garland. ...
... was reported that in community homes at Sutton and Merton, ... This was revealed after a year long investigation by the ... revealed the pathetic living conditions of the inmates. These care ... of them do not possess the right kind of mental ...
... It is a study that affirms the role ... authors. ,Publishing results in the January issue of ... //who train together for skin examination sessions are bound to ... often. This naturally translates to reduced risks of developing the ...
... article in the January issue of Archives of ... journals, measuring a patient's ratio of white blood ... the similar conditions infectious mononucleosis and bacterial tonsillitis, ... (inflammation of the tonsils) and infectious mononucleosis (caused ...
... time proving fatal, at the hands of stomach cancer, according ... put to rest a mystery of 200 years, // regarding ... ,The most recent theory, running since the 1961 discovery of ... ruler’s death was due to arsenic poisoning. ,Publishing results ...
... get first-time heart attacks 5 to 10 years earlier than ... loosely to genes.,Not any more say experts. // , ... published in Journal of the American Medical Association that leave ... Pakistan, Srilanka, Nepal and. Bangladesh) to blame their genes. ...
Cached Medicine News:Health News:Pair Up-Prevent Melanoma 2Health News:Lymphocyte/WBC Ratio Helps in Treating ENT Disorders 2Health News:Mighty Conqueror Felled by Stomach Cancer 2Health News:South Asians, Don’t Blame Your Genes Anymor 2
... Sonys new DFW-SX910 digital camera is equipped ... with square pixels and offers excellent sensitivity ... This camera delivers uncompressed, high-resolution, ... asynchronous electronic shutter function with an exposure ...
... the latest in imaging technology with the 12.5 ... high resolution, high sensitivity, and high-speed data transfer ... fluorescence. CCD - 2/3" Single ... Depth - 36-bit Exposure Range ...
4 megapixel zoom digicam with a 4x optical zoom, Effective pixels:4.0 million CCD:1/1.8-in. type (4.13 million total pixels), Max Image size:2272 (2,272 x 1,704 pixels), Lens:4x Zoom-Nikkor; f = 7.85...
... stand-alone digital camera with networking capability for ... remote locations. Image acquisition and camera manipulation ... independently or attaches directly to a LAN/WAN. ... capture and transfer images. Sharing images in ...
Medicine Products: